SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-21-000033
Filing Date
2021-03-31
Accepted
2021-03-31 16:58:09
Documents
71
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K awh-20201231x10k.htm 10-K 1784332
2 EX-4.7 awh-20201231xex4_7.htm EX-4.7 34602
3 EX-21.0 awh-20201231xex21_0.htm EX-21.0 8382
4 EX-23.1 awh-20201231xex23_1.htm EX-23.1 5164
5 EX-31.1 awh-20201231xex31_1.htm EX-31.1 22346
6 EX-31.2 awh-20201231xex31_2.htm EX-31.2 22602
7 EX-32.0 awh-20201231xex32_0.htm EX-32.0 13234
  Complete submission text file 0000926617-21-000033.txt   7246550

Data Files

Seq Description Document Type Size
8 EX-101.INS awh-20201231.xml EX-101.INS 1477520
9 EX-101.SCH awh-20201231.xsd EX-101.SCH 50903
10 EX-101.CAL awh-20201231_cal.xml EX-101.CAL 57150
11 EX-101.DEF awh-20201231_def.xml EX-101.DEF 190033
12 EX-101.LAB awh-20201231_lab.xml EX-101.LAB 445904
13 EX-101.PRE awh-20201231_pre.xml EX-101.PRE 386396
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 21794277
SIC: 2835 In Vitro & In Vivo Diagnostic Substances